Gastrointestinal stromal tumour – metastatic or unresectable Initial PBS authority application Supporting information form (PB095)

You must lodge this form for a patient starting initial PBS subsidised treatment with imatinib mesylate for metastatic or unresectable malignant gastrointestinal stromal tumour.


Page last updated: 13 July 2016

This information was printed Friday 30 September 2016 from It may not include all of the relevant information on this topic. Please consider any relevant site notices at when using this material.